DNA icon

RPE65-Associated Disorders via the RPE65 Gene

Summary and Pricing

Test Method

Sequencing and CNV Detection via NextGen Sequencing using PG-Select Capture Probes
Test Code Test Copy GenesTest CPT Code Gene CPT Codes Copy CPT Codes Base Price
RPE65 81406 81406,81479 $990
Test Code Test Copy Genes Test CPT Code Gene CPT Codes Copy CPT Code Base Price
7547RPE6581406 81406,81479 $990 Order Options and Pricing

Pricing Comments

Testing run on PG-select capture probes includes CNV analysis for the gene(s) on the panel but does not permit the optional add on of exome-wide CNV analysis. Any of the NGS platforms allow reflex to other clinically relevant genes, up to whole exome or whole genome sequencing depending upon the base platform selected for the initial test.

An additional 25% charge will be applied to STAT orders. STAT orders are prioritized throughout the testing process.

This test is also offered via a custom panel (click here) on our exome or genome backbone which permits the optional add on of exome-wide CNV or genome-wide SV analysis.

Turnaround Time

3 weeks on average for standard orders or 2 weeks on average for STAT orders.

Please note: Once the testing process begins, an Estimated Report Date (ERD) range will be displayed in the portal. This is the most accurate prediction of when your report will be complete and may differ from the average TAT published on our website. About 85% of our tests will be reported within or before the ERD range. We will notify you of significant delays or holds which will impact the ERD. Learn more about turnaround times here.

Targeted Testing

For ordering sequencing of targeted known variants, go to our Targeted Variants page.

EMAIL CONTACTS

Genetic Counselors

Geneticist

  • Dana Talsness, PhD

Clinical Features and Genetics

Clinical Features

Leber Congenital Amaurosis 2 (LCA2) or Severe Early Childhood-Onset Retinal Dystrophy (SECORD) and Retinitis Pigmentosa (RP20) associated with RPE65 pathogenic variants are due to dysfunction and degeneration of photoreceptors (Cideciyan et al. 2013. PubMed ID: 23341635; Weleber et al. 2011. PubMed ID: 20811047). All affected patients have night blindness, a typical and early symptom. LCA2 or SECORD and RP20 are characterized by profound vision loss at birth, variable degrees of nystagmus, high hypermetropia, photodysphoria, oculodigital signs, keratoconus, cataracts and variable appearance to the fundus (Chung and Traboulsi. 2009. PubMed ID: 20006823). Ophthalmoscopy reveals attenuated vessels, atrophy of the optic disc and many whitish dots due to extensive retinal pigment epithelium (RPE) defects (Gu et al. 1997. PubMed ID: 9326941). The estimated prevalence of LCA is 2-3 per 100,000 live births and accounts for 10-18% of congenital blindness (Fazzi et al. 2003. PubMed ID: 12615170). Several clinical features of LCA overlap with those of RP (Perrault et al. 1996. PubMed ID: 8944027; Daiger et al. 2007. PubMed ID: 17296890; Gu et al. 1997. PubMed ID: 9326941). Both LCA and RP are clinically and genetically heterogeneous.

Genetics

LCA is inherited as an autosomal recessive trait in the vast majority of patients, while RP is either sporadic or familial with various modes of Mendelian, mitochondrial or oligogenic inheritance. To date, 14 and 25 genes have been implicated in LCA and autosomal recessive RP (AR-RP), respectively (den Hollander et al. 2008. PubMed ID: 18632300; Daiger et al. 2007. PubMed ID: 17296890). Of note, a pathogenic missense variant in RPE65 was identified by whole-exome sequencing in an autosomal dominant retinitis pigmentosa (with choroidal involvement) affected large Irish family (Bowne et al. 2011. PubMed ID: 21654732). Also, some RPE65 null allele heterozygous carriers may manifest visual symptoms (Felius et al. 2002. PubMed ID: 11786058). The clinical overlap between LCA and RP is illustrated by the involvement of six genes in both conditions. These include RPE65 (Marlhens et al. 1997. PubMed ID: 9326927; Gu et al. 1997. PubMed ID: 9326941), which encodes retinol isomerase, expressed in retinal pigment epithelium (RPE). Retinol isomerase is involved in vitamin A metabolism in the visual cycle to synthesize 11-cis-retinaldehyde. Pathogenic variants in this gene lead to no chromophore production and affect the visual pigments (Weleber et al. 2011. PubMed ID: 20811047).

RPE65 pathogenic variants account for approximately 8% of LCA and have been shown to be influenced by genetic background, environment and other factors (Li et al. 2009. PubMed ID: 18936139). About 30 different RPE65 pathogenic variants have been reported each in patients with LCA2 and RP20. LRAT, RPE65 and RDH12 pathogenic variants lead to similar phenotypes, suggesting the need to screen all these genes systematically (Sénéchal et al. 2006. PubMed ID: 17011878; Weleber et al. 2013. PubMed ID: 20301475). RPE65 pathogenic variants include missense, nonsense, splicing, and small deletions/insertions (mostly frameshift); they are distributed throughout the entire coding region.

Clinical Sensitivity - Sequencing with CNV PG-Select

A preliminary assessment with 176 probands from 9 different countries suggested that few patients affected with Leber Congenital Amaurosis (LCA) exhibit pathogenic variants in RPE65, indicating that LCA is extremely genetically heterogeneous (Lotery et al. 2000. PubMed ID: 10766140). In another study, RPE65 pathogenic variants accounted for ~2% (3 out of 162 cases) of recessive or isolate Retinitis Pigmentosa and ~16% (7 of 45) of LCA cases (Morimura et al. 1998. PubMed ID: 9501220). Thus far, only one gross deletion has been reported involving RPE65 (Al-Gazali and Ali. 2010. PubMed ID: 20437613).

Testing Strategy

This panel provides 100% coverage of all coding exons of the RPE65 gene, plus ~10 bases of flanking noncoding DNA. We define coverage as ≥20X NGS reads or Sanger sequencing.

Indications for Test

Patients with LCA and AR-RP and family members of patients who have known pathogenic variants are candidates. This test may also be considered for the reproductive partners of individuals who carry pathogenic variants in RPE65.

Gene

Official Gene Symbol OMIM ID
RPE65 180069
Inheritance Abbreviation
Autosomal Dominant AD
Autosomal Recessive AR
X-Linked XL
Mitochondrial MT

Diseases

Name Inheritance OMIM ID
Leber Congenital Amaurosis 2 AR 204100
Retinitis Pigmentosa 20 AR, AD 613794

Related Tests

Name
Leber Congenital Amaurosis 14 (LCA14) or Early Onset Retinal Dystrophy (EORD) and Juvenile Retinitis Pigmentosa via the LRAT Gene
Leber Congenital Amaurosis Panel
Retinitis Pigmentosa Panel

Citations

  • Al-Gazali and Ali. 2010. PubMed ID: 20437613
  • Bowne et al. 2011. PubMed ID: 21654732
  • Chung and Traboulsi. 2009. PubMed ID: 20006823
  • Cideciyan et al. 2013. PubMed ID: 23341635
  • Daiger et al. 2007. PubMed ID: 17296890
  • den Hollander et al. 2008. PubMed ID: 18632300
  • Fazzi et al. 2003. PubMed ID: 12615170
  • Felius et al. 2002. PubMed ID: 11786058
  • Gu et al. 1997. PubMed ID: 9326941
  • Li et al. 2009. PubMed ID: 18936139
  • Lotery et al. 2000. PubMed ID: 10766140
  • Marlhens et al. 1997. PubMed ID: 9326927
  • Morimura et al. 1998. PubMed ID: 9501220
  • Perrault et al. 1996. PubMed ID: 8944027
  • Sénéchal et al. 2006. PubMed ID: 17011878
  • Weleber et al. 2011. PubMed ID: 20811047
  • Weleber et al. 2013. PubMed ID: 20301475

Ordering/Specimens

Ordering Options

We offer several options when ordering sequencing tests. For more information on these options, see our Ordering Instructions page. To view available options, click on the Order Options button within the test description.

myPrevent - Online Ordering

  • The test can be added to your online orders in the Summary and Pricing section.
  • Once the test has been added log in to myPrevent to fill out an online requisition form.
  • PGnome sequencing panels can be ordered via the myPrevent portal only at this time.

Requisition Form

  • A completed requisition form must accompany all specimens.
  • Billing information along with specimen and shipping instructions are within the requisition form.
  • All testing must be ordered by a qualified healthcare provider.

For Requisition Forms, visit our Forms page

If ordering a Duo or Trio test, the proband and all comparator samples are required to initiate testing. If we do not receive all required samples for the test ordered within 21 days, we will convert the order to the most effective testing strategy with the samples available. Prior authorization and/or billing in place may be impacted by a change in test code.


Specimen Types

Specimen Requirements and Shipping Details

loading Loading... ×

ORDER OPTIONS

An error has occurred while calculating the price. Please try again or contact us for assistance.

View Ordering Instructions

1) Select Test Method (Platform)


1) Select Test Type


2) Select Additional Test Options

No Additional Test Options are available for this test.

Note: acceptable specimen types are whole blood and DNA from whole blood only.
Total Price: loading
Patient Prompt Pay Price: loading
A patient prompt pay discount is available if payment is made by the patient and received prior to the time of reporting.
Show Patient Prompt Pay Price
×
Copy Text to Clipboard
×